GO306

AXP000109.1 · Oncolytic virus

Platform
vaccinia virus
Originator
GeneSail Biotech
Sponsor
GeneSail Biotech

Names

NameTypeSource
GO306preferred name, codecurator, ctgov

Virus

Role
Oncolytic
Family
Poxviridae
Virus
vaccinia virus (NCBI Taxonomy 10245)
Replication
conditionally replicating
Modifications
not described in the registration
Source
evidence

Approvals

No regulatory approval recorded.

Clinical trials (1)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT07128914A Clinical Study of GO306 in Patients With Advanced Solid TumorsRecruitingPhase 12025-07-312026-12-3132Solid Tumor Malignancies

Recent changes

No changes recorded in its trials yet.

Notes

Recombinant oncolytic vaccinia virus injection; phase 1 in advanced refractory solid tumours (NCT07128914, recruiting since August 2025). Construct and route not described.

How to cite

GO306 (AXP000109.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000109.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.